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The serotoninergic system plays an essential role in the brain. Nerve cells that use serotonin as
neurotransmitter are among the most branched and cross-linked. They are responsible for the
modulation of several processes of the CNS. Therefore, the serotoninergic system is the target
for the therapy of different diseases like depression, pain, schizophrenia and chemotherapy
induced nausea and vomiting. Additionally, several drugs of abuse, like LSD, DMT, Mescalin and
Psilocybin are acting directly on this system.
After serotonin (5-hydroxytryptamine, 5-HT) is released into the synaptic cleft, the natural
agonist binds to different receptors. Seven classes of receptors have been described too date,
most of them are GPCRs (5-HT1-2,4-7R), only the 5-HT3R is an ion channel belonging to the Cys-
loop superfamily of transmembrane receptors. The 5-HT3R is assembled from 5 subunit
positioned around the central pore. It is permeable to sodium, potassium and calcium. Recently,
the crystal structure of the mouse 5-HT3R was solved and reported using x-ray analysis.
[1] This
structure was stabilized by nanobodies, deeply binding into the orthosteric binding site, that
leaves unanswered questions in the understanding of the pharmacology of the receptor.
Since few years our research focused on the study of the structure and pharmacology of
5-HT3R. We report here our most recent results. Different approaches were applied. Starting
from FDA approved antagonists we synthesised several probes (fluorescent,[2] photoaffinity[3]
and PET[4]) and their behaviour was investigated. Most of them show very high binding affinity
(low nM or even pM) and could be used as tools in microscopy, PET and proteomic analyses.
Furthermore we established a stable h5-HT3R expressing cell line and a purification protocol to
yield the receptor in a high purity. 
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